Terrance McGuire Net Worth & Insider Trades

Terrance McGuire - Director, Cyclerion Therapeutics, Inc

As of August 11, 2023

What is Terrance McGuire's Net Worth?

The current estimated net worth of Cyclerion Therapeutics, Inc's Director, Terrance McGuire, is estimated to be about $196.16M . Terrance McGuire owns about 552 units of Cyclerion Therapeutics, Inc common stock. In the last 4 years at Cyclerion Therapeutics, Inc, Terrance McGuire has sold an estimated value of $27.16 worth.

What is Terrance McGuire's Past Insider Trading?

Terrance McGuire's largest purchase order was 626,117 units , worth over $10.02M on April 10, 2019. Terrance McGuire's largest sale order was 8 units , worth over $27.16 on August 11, 2023. In total, Terrance McGuire has made about 8 transactions over 4 years of their time at Cyclerion Therapeutics, Inc. Terrance McGuire usually trades in June, with the busiest year in 2019.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TERRANCE MCGUIRE

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Terrance McGuire's' Mailing Address?

  • Mailing address is C/o Polaris Venture Partners Lp 1000 Winter Street, Suite 3350 Waltham MA 02154 MA

What are Cyclerion Therapeutics, Inc's Past Insider Trades?

Cyclerion Therapeutics, Inc's most recent insider trade came on August 11, 2023 by Terrance McGuire who sold 8 units worth $27.16 . In the last 4 years, insiders at Cyclerion Therapeutics, Inc have sold an estimated value of $240.02K and bought an estimated value of $34.97M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Peter Hecht, Chief Executive Officer,  Terrance McGuire, Director,  and Andreas Busch, Chief Scientific Officer .

Cyclerion Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...